BEUDAMED
    230 results · 18ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Eu Ivdd ×

    Reaction Tube With Cap

    Device
    EU IVDD · Eu Ivd General ·Nantong EgensBiotechnology Co.,Ltd.·No longer on the market

    Novel Coronavirus (2019-nCoV) Antigen Rapid Test

    Basic UDI-DI
    EU IVDD · Eu Ivd General ·Tianjin Bioscience Diagnostic Technology Co.,Ltd.·1 device

    Reaction Tube With Cap

    Basic UDI-DI
    EU IVDD · Eu Ivd General ·Nantong EgensBiotechnology Co.,Ltd.·1 device

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market